Elite Pharmaceuticals Inc (ELTP)
Elite Pharmaceuticals Market Cap: 152.06M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 145.54M |
May 16, 2024 | 141.47M |
May 15, 2024 | 142.39M |
May 14, 2024 | 141.98M |
May 13, 2024 | 138.01M |
May 10, 2024 | 138.01M |
May 09, 2024 | 128.49M |
May 08, 2024 | 134.35M |
May 07, 2024 | 137.40M |
May 06, 2024 | 146.05M |
May 03, 2024 | 132.12M |
May 02, 2024 | 131.48M |
May 01, 2024 | 131.43M |
April 30, 2024 | 132.00M |
April 29, 2024 | 137.40M |
April 26, 2024 | 134.86M |
April 25, 2024 | 131.80M |
April 24, 2024 | 128.55M |
April 23, 2024 | 125.39M |
April 22, 2024 | 129.46M |
April 19, 2024 | 132.31M |
April 18, 2024 | 135.87M |
April 17, 2024 | 138.21M |
April 16, 2024 | 137.65M |
April 15, 2024 | 137.40M |
Date | Value |
---|---|
April 12, 2024 | 142.49M |
April 11, 2024 | 142.37M |
April 10, 2024 | 143.20M |
April 09, 2024 | 143.46M |
April 08, 2024 | 141.22M |
April 05, 2024 | 142.49M |
April 04, 2024 | 140.25M |
April 03, 2024 | 142.49M |
April 02, 2024 | 155.72M |
April 01, 2024 | 155.72M |
March 28, 2024 | 157.08M |
March 27, 2024 | 155.72M |
March 26, 2024 | 155.06M |
March 25, 2024 | 154.50M |
March 22, 2024 | 153.89M |
March 21, 2024 | 155.58M |
March 20, 2024 | 151.65M |
March 19, 2024 | 144.63M |
March 18, 2024 | 146.56M |
March 15, 2024 | 146.54M |
March 14, 2024 | 141.47M |
March 13, 2024 | 140.96M |
March 12, 2024 | 136.38M |
March 11, 2024 | 147.68M |
March 08, 2024 | 154.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 6.730M |
Palatin Technologies Inc | 32.43M |
iBio Inc | 7.456M |
Theriva Biologics Inc | 6.531M |
Oragenics Inc | 13.04M |
Market Cap Related Metrics
PE Ratio | 14.10 |
PS Ratio | 3.215 |
PEG Ratio | 0.1136 |
Price to Book Value | 3.276 |
Price | 0.1494 |
Earnings Yield | 7.09% |
PEGY Ratio | 0.1136 |
Operating PE Ratio | 21.84 |
Normalized PE Ratio | 11.05 |